New publication: Healing Damaged Joints with Regenerative Medicine

Healing Damaged Joints with Regenerative Medicine

Rheumatic diseases and osteoarthritis (OA) affect millions of people, often in ways that remain invisible. In the Netherlands alone, more than 2.5 million people live with chronic pain, fatigue, and daily limitations.

At ICAT, we contribute to the future of healthcare by enabling the development of advanced therapies that go beyond symptom management—focusing instead on restoring damaged tissues and improving long-term patient outcomes.

New publication published

We are proud to contribute to and share the new RegMed XB publication:
“Healing Damaged Joints with Regenerative Medicine”

This publication showcases the latest developments and collaborations within the RegMed XB ecosystem, including:

• Insights from Frank Luyten, Professor Emeritus of Rheumatology at KU Leuven / UZ Leuven and Medical Scientific Director of RegMed XB
• The RegMed XB Pilot Factory and its pilot lines, including ICAT - Innovation Center for Advanced Therapies (ICAT), Leiden University Medical Center, NecstGen, ReGEN Biomedical, and Smart BioMaterials Center (SBMC)
• The role of advanced technologies such as 3D Bioprinting, including perspectives from Maaike Braham, Regenerative Medicine and Tissue Engineering Specialist at ICAT

Building the future of regenerative medicine

Together with our partners, ICAT is helping to build the infrastructure, technologies, and therapies needed to make regenerative medicine a reality for patients today and in the future.

Download the publication here